Short-term Safety and Tolerability of a Once-Daily Fixed-Dose Abacavir-Lamivudine Combination versus Twice-Daily Dosing of Abacavir and Lamivudine as Separate Components: Findings from the ALOHA Study

✍ Scribed by Dr. Calvin J. Cohen; Dr. Marshall Kubota; Dr. Philip S. Brachman; Dr. William B. Harley; Dr. Stefan Schneider; Ms. Vanessa C. Williams; Dr. Denise H. Sutherland-Phillips; Dr. Michael L. Lim; Dr. Rukmini B. Balu; Dr. Mark S. Shaefer

• Book ID: 115049696
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 84 KB
• Volume: 28
• Category: Article
• ISSN: 0277-0008
• DOI: 10.1592/phco.28.3.314